Norman Lippmann
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
- Epidemiology 10
-
- Antibiotic Resistance in Bacteria 8
- Co-authors
- Christoph Lübbert (19 shared papers)Arne C. Rodloff (11 shared papers)Martina Kinzig (1 shared paper)Fritz Sörgel (1 shared paper)Thilo Busch (2 shared papers)Tim Eckmanns (2 shared papers)Udo X. Kaisers (2 shared papers)Tanja Ducomble (1 shared paper)
In The Last Decade
Norman Lippmann
34 papers receiving 520 citations
Peers
Comparison fields: 5 of 89
- Molecular Medicine 153
- Applied Microbiology and Biotechnology 56
- Endocrinology 51
- Pollution 96
- Clinical Biochemistry 29
Countries citing papers authored by Norman Lippmann
This map shows the geographic impact of Norman Lippmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Lippmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Lippmann more than expected).
Fields of papers citing papers by Norman Lippmann
This network shows the impact of papers produced by Norman Lippmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Lippmann. The network helps show where Norman Lippmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Norman Lippmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 134 | |
| 2 | 2014 | 68 | |
| 3 | 2017 | 42 | |
| 4 | 2016 | 41 | |
| 5 | 2021 | 30 | |
| 6 | 2021 | 27 | |
| 7 | 2017 | 21 | |
| 8 | 2020 | 19 | |
| 9 | 2020 | 18 | |
| 10 | 2021 | 17 | |
| 11 | 2020 | 11 | |
| 12 | 2020 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 8 | |
| 15 | 2024 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 7 | |
| 18 | 2023 | 6 | |
| 19 | 2023 | 5 | |
| 20 | 2022 | 5 |
About Norman Lippmann
Norman Lippmann is a scholar working on Epidemiology, Molecular Medicine, Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery, having authored 38 papers that have together received 537 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (8 papers), Surgical site infection prevention (5 papers), Photodynamic Therapy Research Studies (4 papers), Streptococcal Infections and Treatments (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Orthopedic Infections and Treatments (3 papers), Nosocomial Infections in ICU (3 papers) and Gallbladder and Bile Duct Disorders (3 papers). The work is most often cited by research in Molecular Medicine (153 citations), Applied Microbiology and Biotechnology (56 citations), Endocrinology (51 citations), Pollution (96 citations) and Clinical Biochemistry (29 citations). Norman Lippmann has collaborated with scholars based in Germany, Ethiopia and Czechia. Frequent co-authors include Christoph Lübbert, Arne C. Rodloff, Martina Kinzig, Fritz Sörgel, Thilo Busch, Tim Eckmanns, Udo X. Kaisers, Tanja Ducomble, Brigitte König and Sebastian Wendt. Their work appears in journals such as PLoS ONE, American Journal of Infection Control, Scientific Reports, Infection and Surgical Infections.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.